Research & Development
Pathology & AI
Study: Proteomic profiling used to track effects of aging, diseases on the eyes
In a study published in
, researchers used proteomic profiling and artificial intelligence (AI) modeling to determine biomarkers and track the progression and effects of aging and disease on the eyes.
October 24, 2023
Thermo Fisher to acquire proteomics firm Olink
Thermo Fisher has announced plans to acquire Uppsala, Sweden-based proteomics company Olink for approximately $3.1 billion. The amount includes net cash of approximately $143 million.
October 17, 2023
NIH awarding $50.3M to establish multiomics consortium
The U.S. National Institutes of Health (NIH) announced that it will award $50.3 million over five years to establish a multiomics research consortium.
September 14, 2023
Proteomics study finds plasma proteins linked with type 2 diabetes, diabetic complications
An analysis of plasma proteins found to be linked with type 2 diabetes and diabetic complications may help develop therapeutic targets, researchers write in an article published in
Cell Reports Medicine
September 8, 2023
BigOmics outlines expansion, omics pipeline
BigOmic’s plan includes providing a more complete pipeline for end-to-end analysis of transcriptomics and proteomics data, according to an interview with GenomeWeb.
August 28, 2023
Vector Laboratories buys Quanta Bio for polyethylene glycol technology
Single molecular weight, discrete-length PEG chains such as Quanta’s dPEG products can simplify peptide analysis compared to other products that contain a range of PEG chain lengths and molecular weights.
July 24, 2023
Bio-Techne to acquire Swiss spatial biology firm Lunaphore
Bio-Techne said that it expects to close the deal by the end of September, in the first quarter of its fiscal 2024.
June 22, 2023
Scanning ion conductance spectroscopy in study enables precise DNA identification
The scanning ion conductance spectroscopy system slows a molecule’s transit through a nanopore, allowing thousands of consecutive readings to be taken of the same molecule, as well as of different locations on the molecule.
June 21, 2023
SeekIn announces validation of AI-enabled multicancer early detection test
In the study, the AI-enabled OncoSeek MCED demonstrated a sensitivity of 51.7% with a specificity of 92.9%, resulting in 84.3% accuracy, with 49.5% sensitivity in stages I and II patients.
June 16, 2023
Thermo Fisher Scientific, Seer expand collaboration to broaden access to mass-spec proteomics
Seer will establish the Seer Technology Access Center to showcase its latest product, the Proteograph XT Assay Kit, in combination with the Thermo Scientific Orbitrap Astral mass spectrometer.
June 7, 2023
Biodesix touts cost-saving potential of pulmonary nodule tests
Its analyses estimated cost savings in a hypothetical population of one million patients in a U.S. Medicare or commercial payer setting over a two-year timeline.
May 30, 2023
SomaLogic CEO steps down; Q4 revenue declines 18%
SomaLogic is at a stage where it needs "seasoned leaders to accelerate market adoption," said Troy Cox, executive chairman of the board of directors.
March 29, 2023
Page 1 of 2